An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
View/ Open
Volume
11
DOI
10.1371/journal.pone.0158526
Journal
PLOS ONE
Issue
ISSN
1932-6203
Metadata
Show full item recordAuthors
Asselah, T; Moreno, C; Sarrazin, C; Gschwantler, M; Foster, GR; Craxi, A; Buggisch, P; Ryan, R; Lenz, O; Scott, JCollections
- Centre for Immunobiology [1013]